Vol 31, No 3 (2024)
Letter to the Editor
Published online: 2024-05-22
Quality of life and functioning in chronic disease — what to assess in heart failure patients
1
Abstract
Not available
References
- Johansson I, Joseph P, Balasubramanian K, et al. G-CHF Investigators. Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries. Circulation. 2021; 143(22): 2129–2142.
- Jonik S, Marchel M, Pędzich-Placha E, et al. Long-term outcomes and quality of life following implementation of dedicated mitral valve Heart Team decisions for patients with severe mitral valve regurgitation in tertiary cardiovascular care center. Cardiol J. 2024; 31(1): 62–71.
- Major K, Bodys-Pełka A, Grabowski M, et al. Quality of life in heart failure: New data, new drugs and devices. Cardiol J. 2024; 31(1): 156–167.
- Kosobucka A, Michalski P, Pietrzykowski Ł, et al. The impact of readiness to discharge from hospital on adherence to treatment in patients after myocardial infarction. Cardiol J. 2022; 29(4): 582–590.
- Kubica A, Kosobucka A, Fabiszak T, et al. Assessment of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention. Is there a place for newself-reported questionnaires? Curr Med Res Opin. 2019; 35(2): 341–349.
- Kubica A, Pietrzykowski Ł, Michalski P, et al. The occurrence of cardiovascular risk factors and functioning in chronic illness in the Polish population of EUROASPIRE V. Cardiol J. 2022 [Epub ahead of print].
- Kubica J, Kubica A, Grzelakowska K, et al. Inhibitors of sodium-glucose transport protein 2: A new multidirectional therapeutic option for heart failure patients. Cardiol J. 2023; 30(1): 143–149.
- Kubica A, Kubica J. Functioning in chronic disease — a key factor determining adherence to heart failure treatment. Medical Research Journal. 2022; 7(4): 277–279.
- Kubica A, Michalski P, Kasprzak M, et al. Functioning of patients with post-COVID syndrome — preliminary data. Medical Research Journal. 2021; 6(3): 224–229.
- Kubica J, Adamski P, Gorog D, et al. Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial. Cardiology Journal. 2022; 29(1): 148–153.
